DE60123235D1 - Regulation einer nf-at interagierenden proteinvariante nip 45 - Google Patents

Regulation einer nf-at interagierenden proteinvariante nip 45

Info

Publication number
DE60123235D1
DE60123235D1 DE60123235T DE60123235T DE60123235D1 DE 60123235 D1 DE60123235 D1 DE 60123235D1 DE 60123235 T DE60123235 T DE 60123235T DE 60123235 T DE60123235 T DE 60123235T DE 60123235 D1 DE60123235 D1 DE 60123235D1
Authority
DE
Germany
Prior art keywords
nip
interacting protein
regulation
activation
protein version
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60123235T
Other languages
English (en)
Other versions
DE60123235T2 (de
Inventor
Jeffrey Encinas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Application granted granted Critical
Publication of DE60123235D1 publication Critical patent/DE60123235D1/de
Publication of DE60123235T2 publication Critical patent/DE60123235T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE60123235T 2000-04-25 2001-04-25 Regulation einer nf-at interagierenden proteinvariante nip 45 Expired - Fee Related DE60123235T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19935600P 2000-04-25 2000-04-25
US199356P 2000-04-25
PCT/EP2001/004635 WO2001081574A2 (en) 2000-04-25 2001-04-25 Regulation of nf-at interacting protein nip 45 variant

Publications (2)

Publication Number Publication Date
DE60123235D1 true DE60123235D1 (de) 2006-11-02
DE60123235T2 DE60123235T2 (de) 2007-09-13

Family

ID=22737188

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60123235T Expired - Fee Related DE60123235T2 (de) 2000-04-25 2001-04-25 Regulation einer nf-at interagierenden proteinvariante nip 45

Country Status (8)

Country Link
EP (1) EP1280897B1 (de)
JP (1) JP2003530883A (de)
AT (1) ATE340261T1 (de)
AU (1) AU2001254813A1 (de)
DE (1) DE60123235T2 (de)
DK (1) DK1280897T3 (de)
ES (1) ES2272471T3 (de)
WO (1) WO2001081574A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002214005A1 (en) * 2000-10-10 2002-04-22 Bayer Aktiengesellschaft Regulation of nf-at interacting protein nip 45 like protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1225682A (zh) * 1996-04-23 1999-08-11 哈佛大学校长及研究员协会 通过调节转录因子活性调节t细胞亚群
GB9722388D0 (en) * 1997-10-24 1997-12-24 Zeneca Ltd NIP45 human homolog

Also Published As

Publication number Publication date
WO2001081574A2 (en) 2001-11-01
EP1280897B1 (de) 2006-09-20
WO2001081574A3 (en) 2002-04-18
ES2272471T3 (es) 2007-05-01
JP2003530883A (ja) 2003-10-21
DE60123235T2 (de) 2007-09-13
EP1280897A2 (de) 2003-02-05
ATE340261T1 (de) 2006-10-15
AU2001254813A1 (en) 2001-11-07
DK1280897T3 (da) 2007-01-08

Similar Documents

Publication Publication Date Title
ATE272110T1 (de) Isolierung von nukleinsäuren
AU2002365811A1 (en) Methods for the selection and cloning of nucleic acid molecules free of unwanted nucleotide sequence alterations
WO2002074979A3 (en) Expression profiles and methods of use
RS51847B (en) BINDING MOLECULES WHICH MAY NEUTRALIZE FRAGILE VIRUS AND USE
RS54133B1 (en) ANTI-IL-6 ANTIBODIES, PREPARATIONS, PREPARATION AND USE PROCEDURES
WO2002004488A3 (en) Nucleic acid binding polypeptides
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
ATE404587T1 (de) Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen
WO2000069896A3 (en) Molecular interactions in haematopoietic cells
DE60138715D1 (de) Tnf-rezeptor-ähnliche moleküle und deren anwendungen
WO2001048209A3 (en) Genes identified as required for proliferation of e. coli
WO2002012478A3 (en) Methyl-d-erythritol phosphate pathway genes
WO2000053776A3 (en) Human kallikrein-like genes
WO2003040181A3 (de) Gene aus corynebacterium glutamicum die für regulatorische proteine codieren
WO2003046123A3 (de) Mutierte gene aus corynebacterium glutamicum
DE60123235D1 (de) Regulation einer nf-at interagierenden proteinvariante nip 45
ATE427959T1 (de) Gereinigtes sr-p70 protein
WO2002030972A3 (en) Regulation of nf-at interacting protein nip 45 like protein
WO2001085935A3 (en) Endothelial differentiation gene 6-like g protein coupled receptor
WO2003002599A3 (en) Immune-related proteins and the regulation of the same
DE602006004966D1 (de) Intrinsic-faktor vom schwein
WO2002031512A3 (en) Molecular interactions in hematopoietic cells
ATE340188T1 (de) Transkriptionsfaktoren welche zwei potentielle dna bindende motive enthalten
KR20040053279A (ko) 스트레스 저항성 및 내성 단백질을 코딩하는 유전자
WO2000069898A8 (en) Molecular interactions in allergy cells

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee